PART TWO: THE CANCER QUESTION — WHAT WAS SAID IN THE RECORDED MEETING

February 13, 2026

Share this article

Undercover footage raises further questions about how regenerative therapies are discussed with vulnerable patients

This is Part Two of an ongoing investigation into Wellbeing International Foundation and the individuals connected to its promotion of regenerative treatments. Part One examined recorded admissions regarding qualifications and professional roles.


During the same face-to-face meeting captured on video, undercover investigators questioned Stephen Ray — described as Chief Scientist — about claims surrounding the potential use of treatments in individuals suffering from serious illnesses, including cancer.


The exchange has prompted renewed discussion about how emerging therapies are communicated to patients and where legal boundaries may lie under UK law.


WHAT WAS SAID ON CAMERA


Throughout the conversation, Ray emphasised that he does not perform medical procedures himself and described his role as explaining scientific concepts rather than delivering clinical care.

When questioned about the effectiveness of treatments, he stated:


“I can speak to the science… I don’t do the medical treatment because I’m not a doctor.”

Investigators challenged him directly with concerns raised by external medical experts, suggesting that authorities in multiple countries were examining the company’s activities.

Ray responded by defending the underlying science and stating his belief that the approach works, while maintaining that patients ultimately decide whether to proceed.

The recording does not show Ray presenting himself as a licensed medical practitioner.


HOW THE PROCESS WAS DESCRIBED


In the discussion, Ray outlined a process involving:

  • blood taken from the patient
  • laboratory handling overseas
  • re-introduction of material into the body at a later date


He described the therapy as involving “secretions that come off the stem cells,” rather than direct stem-cell transplantation.


When asked whether he believed the procedure treats people, Ray answered:


“Yes it does… based on the research we’ve actually done.”

THE LEGAL CONTEXT: THE CANCER ACT 1939


The recorded conversation included references to serious illnesses, prompting questions about the legal framework governing medical advertising in the United Kingdom.


Under the Cancer Act 1939, it is a criminal offence to advertise or promote treatments claiming to cure cancer unless specific exemptions apply. The law was introduced to protect vulnerable individuals from unproven or misleading medical claims.


This investigation does not allege that Ray personally breached the Act. However, legal experts say that any discussion linking treatments to serious diseases must be handled with extreme care, particularly when presented to prospective patients.


One healthcare regulatory analyst told this publication:


“The key issue is not just what is said — but how it might be interpreted by someone seeking hope for a serious condition.”

SCIENCE, SALES — OR SOMETHING IN BETWEEN?


During the meeting, Ray positioned himself as a communicator of scientific theory rather than a clinician.

He stated that his role was to explain what the treatment could and could not do, while acknowledging that final decisions rested with patients.


Critics argue that the distinction between scientific explanation and medical recommendation can become blurred when discussions take place in prestigious medical environments such as Harley Street — a location widely associated with high-level clinical expertise.


OFFSHORE STRUCTURES AND GOVERNANCE QUESTIONS


When asked why the organisation connected to the treatments was registered in Bermuda, Ray said:


“Max has got various business interests over there… I just deal with the science.”

The comment adds to ongoing questions about corporate structure and oversight raised in Part One of this investigation, which examined the business histories of key figures linked to the organisation.


WHY THIS RECORDING MATTERS


The significance of the footage lies not in a single statement, but in what it reveals about the wider ecosystem surrounding emerging regenerative therapies:

  • non-medical scientific figures interacting with prospective clients
  • complex international corporate structures
  • treatments described in scientific rather than clinical terms

Supporters argue that innovative therapies often sit on the edge of traditional regulation. Critics counter that vulnerable individuals may struggle to distinguish between scientific discussion and medical advice.


THE INVESTIGATION CONTINUES


Wellbeing International Foundation has not responded to detailed questions at the time of publication.

This investigation will continue to examine how emerging therapies are presented to the public, how corporate structures influence patient access, and how regulators across multiple jurisdictions respond to rapidly evolving claims.


Recent Posts

May 15, 2026
For months, investigators have examined the digital footprint, corporate structure, public marketing, and leadership profiles connected to Wellbeing International Foundation Ltd.
May 15, 2026
As investigators continued examining the structure behind Wellbeing International Foundation Ltd,
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION TESTIMONIALS
May 10, 2026
WELLBEING INTERNATIONAL FOUNDATION LTD: “ETHICAL HEALING”
May 3, 2026
The commercial stem cell industry has grown rapidly over the past decade, with clinics around the world advertising regenerative medicine programs for conditions ranging from chronic pain to neurological disorders. Among the most controversial areas is autism. Families searching online are now routinely exposed to clinics promoting stem cell therapies as potential solutions for behavioural, developmental, or communication difficulties associated with autism spectrum disorder (ASD). But according to major medical authorities, parents should be extremely careful before committing to expensive experimental treatments. No Major Regulator Has Approved Stem Cell Therapy For Autism At present: The U.S. Food and Drug Administration has not approved stem cell therapy as a treatment for autism. The National Health Service does not recognise stem cell therapy as a standard autism treatment. European regulators continue treating most autism-related stem cell therapies as experimental. Researchers continue studying the field. But experimental science and established medical treatment are not the same thing. The Problem With Commercial Marketing Critics argue that some clinics blur the line between scientific possibility and proven outcome. Common marketing techniques include: Emotional recovery stories Before-and-after videos Technical medical language Claims of “advanced” therapy References to inflammation or neurological repair However, many scientists say evidence supporting these claims remains limited or inconclusive. Understanding Autism Complexity Autism is not a single illness. It is a broad developmental spectrum involving: Communication differences Behavioural traits Sensory variation Neurological diversity Because autism naturally develops differently in every child, measuring treatment success becomes highly complicated. Experts warn that developmental progress may sometimes occur naturally over time regardless of experimental intervention. What Treatments Have Better Scientific Support? While no treatment cures autism, specialists generally recommend evidence-based support approaches such as: Speech and language therapy Occupational therapy Behavioural intervention Educational support Social development programs Family support services Major organisations providing evidence-based information include: National Autistic Society https://www.autism.org.uk/ Centers for Disease Control and Prevention https://www.cdc.gov/autism/ World Health Organization https://www.who.int/ Autism Speaks https://www.autismspeaks.org/ Questions Families Should Ask Before Paying Experts recommend parents ask: Is this treatment regulator-approved? What peer-reviewed evidence exists? What are the known risks? What percentage of patients show no benefit? Are claims independently verified?  Evidence Before Emotion Families searching for hope deserve compassion, transparency, and honesty. Stem cell science remains an active research field. But until stronger clinical evidence exists, many experts believe autism-related stem cell treatments should be approached with serious caution — particularly when large sums of money and vulnerable families are involved.
May 3, 2026
As commercial stem cell clinics continue expanding across Europe and beyond, increasing numbers of families affected by autism are being introduced to expensive regenerative medicine programs marketed as cutting-edge alternatives to conventional therapy. One organisation repeatedly mentioned during conversations with former clients and concerned families is Wellbeing International Foundation LTD. This article does not accuse the clinic of criminal behaviour or fraud. However, as concerns surrounding commercial autism-related stem cell treatments continue growing internationally, experts say families should approach all such clinics with careful scrutiny. Why Autism Has Become A High-Interest Market Autism spectrum disorder affects millions of families worldwide. Because there is no single cure — and because developmental progress can vary enormously from child to child — families are often vulnerable to treatments marketed as innovative or revolutionary. Investigators reviewing the regenerative medicine sector have identified repeated themes in clinic advertising: Hope-based messaging Emotional testimonials Scientific jargon “Breakthrough” language Claims of advanced neurological repair Large financial commitments For many parents, distinguishing between genuine science and commercial optimism can become extremely difficult. THE MAIN WARNING SIGNS 🚩 Clinics Suggesting One Treatment Can Help Many Conditions Experts urge caution when the same therapy is promoted for: Autism Neurological disease Chronic pain Anti-ageing Immune conditions Degenerative illness Complex medical conditions require highly specific evidence. 🚩 Testimonials Used As Primary Evidence Powerful personal stories can influence emotions deeply. But regulators repeatedly warn that testimonials alone do not prove clinical effectiveness. 🚩 Scientific Terminology Without Clear Proof Families should ask clinics to clearly explain: How treatments work What evidence exists What outcomes are independently verified Complicated language is not the same as scientific certainty. 🚩 Significant Financial Commitments Many families report spending very large sums on: Consultations Treatment programs Flights Accommodation Repeat procedures without guaranteed outcomes. 🚩 Overseas Structures And Limited Oversight International treatment arrangements can complicate: Legal accountability Consumer rights Medical regulation Long-term follow-up The Ethics Of Hope Medical ethics experts have increasingly raised concerns about the emotional vulnerability of families searching for autism support. Parents naturally want to help their children. That emotional reality can make high-promise treatments especially persuasive. Critics argue that hope should never be marketed in a way that risks creating unrealistic expectations.  Questions Families Should Always Ask Before committing to any stem cell-based autism treatment, families should request: Published evidence Independent clinical data Long-term outcomes Full risk disclosures Regulatory status information Transparency matters. Especially when vulnerable families are involved.
May 3, 2026
For many parents raising children with autism, life becomes a constant search for answers. Therapies. Specialists. Diets. Support groups. New research. Alternative medicine. And increasingly, stem cell clinics. Over recent months, Investigations Desk has spoken with families who say they pursued expensive regenerative medicine treatments for autistic children after being exposed to persuasive marketing campaigns promising potential improvements in communication, behaviour, focus, and cognitive function. One parent — who we will identify only as Mr X to protect the child’s privacy — described a journey that began with optimism but eventually turned into doubt. According to Mr X, the family underwent multiple treatment procedures after being encouraged to believe stem cell-based therapies could potentially assist with autism-related symptoms. Initially, every small behavioural change felt significant. But over time, the family says they began questioning whether the treatments had actually produced any measurable improvement at all. “You want to believe something is happening,” Mr X explained. “As a parent, you analyse every little change because you desperately want your child to improve.” The family says the emotional pressure surrounding the process made objective judgment increasingly difficult. The Rise Of Autism As A Commercial Treatment Market Autism spectrum disorder has become one of the fastest-growing target areas within the global regenerative medicine industry. Across websites and social media platforms, clinics frequently advertise: Stem cell therapy Exosome therapy Neuro-regenerative medicine Immune modulation programs Cellular repair treatments Many use emotional testimonials alongside highly technical scientific language which can be difficult for ordinary families to independently verify. Investigators examining this sector have repeatedly identified recurring marketing patterns: Dramatic recovery stories Scientific terminology with limited explanation Expensive treatment packages Overseas treatment arrangements “Breakthrough” medical language Claims that conventional medicine is “behind” What Science Currently Says Despite aggressive online marketing, there is currently no universally accepted regulator-approved stem cell cure for autism. Research into stem cells and neurological conditions does exist. However, leading experts continue warning that experimental research should not be confused with established medical treatment. Autism itself is an extremely complex developmental condition involving a broad spectrum of behavioural and neurological differences. That complexity makes it particularly difficult to scientifically measure treatment claims being promoted commercially. Hope And Vulnerability Parents affected by autism are not foolish for exploring possibilities. They are hopeful. And hope can become extremely powerful when families feel conventional support systems are slow, limited, or overwhelmed. Critics of the commercial stem cell industry argue that some clinics may unintentionally blur the line between experimental science and proven medical outcomes. That concern is now drawing increasing international attention from regulators, scientists, and consumer protection groups.  The Bigger Question Mr X says the family eventually decided to speak privately with investigators after recognising similarities between their experience and concerns now being raised globally about commercial regenerative medicine businesses. “We’re not against research,” he said. “But families need to know the difference between evidence and hope.” That distinction may now sit at the heart of one of the most controversial debates in modern alternative medicine.
April 24, 2026
There is a pattern. Once you’ve seen it, you can’t unsee it.
Show More